 |
OncoCyte
Last updated: April 15, 2024
Cavan Redmond (Chairman) and William Annett (CEO)
Country: USA | Funding: $73M (+)
Website: http://www.oncocyte.com/
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
Website: http://www.oncocyte.com/
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
